Valiant Laboratories Limited (BOM:543998)
67.90
-1.08 (-1.57%)
At close: Jun 19, 2026
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.69 billion as of June 18, 2026. Its market cap has decreased by -17.70% in one year.
Market Cap
3.69B
Enterprise Value
3.82B
Revenue
2.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
67.90
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.69B, a decrease of -50.15%. That is a compound annual growth rate of -22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 3.69B | -3.00% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amanta Healthcare | 5.37B |
| Jenburkt Pharmaceuticals | 5.20B |
| Albert David | 4.05B |
| Medico Remedies | 3.56B |
| Trident Lifeline | 2.98B |
| Medicamen Biotech | 2.85B |
| Astonea Labs | 2.82B |
| Everest Organics | 2.63B |